RICO, I bought shares in this company in late January-early Feb. I am watching closely because I have one very important concern.
The result of the phase 3 will be good, there is no question. This is not a secret, yet the street knowing this values the the company at about only $5 pps since the company has roughly $2 pps in cash. WHY?
The answer might be in the quality of the deal it has with Bayer, as well as other competitive drugs as well as PFEs. PFE only has a portion of their drug, sharing the market with other drugs, so I don't know if PFE will buy this company.
My worry is that the p3 result, may already be factored into the pps. There may be a pop upon release of results, but my belief it will go to roughly $10- $15pps. Personally, that will be my exit point. JMHO
Yes sir, the one and only ruby that has been here 20 years or so.
Interesting point, for the last 6 Fridays the stock has closed up. Prior to that it has been up the vast majorities of months before that.
It is common for some sort of news to come out over the weekends. E.g. Barron's on several weekend editions. Being short over the weekends has been a recipe for disaster.